AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Birth Cohort Study of China Medical University

Recruitingn/aAges 18 Years - anyFemaleShengjing Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The CMUBCS is a birth cohort study located in Shenyang, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology. Data are collected regarding environmental factors, family and lifestyle, clinical experimental outcomes and imaging results of pregnant women and children from birth to 18 years old. Biological samples including blood and tissue samples are also collected from the children and their parents.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Pregnant women, \<13 gestational weeks 2. Permanent residents or families intended to remain in Shenyang and surrounding areas 3. Pregnant women who are planned to be examined and delivered in Shengjing Hospital. Exclusion Criteria: 1. Pregnant women who refuse to take part in the study 2. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Shengjing Hospital
Shenyang, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy